-
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of "Moderate Buy" by Analysts
Source: Buzz FX / 06 Mar 2025 02:26:14 America/New_York
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 6, 2025 Share Link copied to clipboard. Shares of Amicus Therapeutics, Inc.
Read more...